Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis

Cancer. 1990 May 1;65(9):1937-41. doi: 10.1002/1097-0142(19900501)65:9<1937::aid-cncr2820650911>3.0.co;2-w.

Abstract

A 1-month-old boy with familial erythrophagocytic lymphohistiocytosis (FEL) had a barely detectable natural killer (NK) activity of 0% to 7% (median, 0.5%) with an effector/target ratio of 20:1. The number of Leu7+ and Leu11+ cells was within normal range. In terms of interleukin-2 (IL-2) receptor antigens, IL-2R/p55 (Tac) was marginally expressed whereas IL-2R/p75 related antigen recognized by YTA-1 monoclonal antibody (MAb),i.e., YTA-1 antigen, was moderately expressed on the patient's mononuclear cells. Since the NK activity was restored in vitro by IL-2 stimulation, insufficient in vivo IL-2 production or altered cooperation of IL-2R/p75 and IL-2R/p55 (Tac) in the IL-2 mediated immune response was suspected to be present. The induction of IL-2R/p55 (Tac) in vitro was found to be imparied after stimulation with IL-2, or YTA-1MAb. When the patient attained remission the IL-2R/p55 (Tac) induction had normalized, but low NK activity persisted. The results indicate that the IL-2/IL-2R system may play an important role in the etiology and pathogenesis of FEL.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Cells, Cultured
  • Histiocytosis, Non-Langerhans-Cell / genetics
  • Histiocytosis, Non-Langerhans-Cell / immunology*
  • Humans
  • Infant, Newborn
  • Interleukin-2 / pharmacology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Lymphocytes / drug effects
  • Lymphocytes / immunology
  • Male
  • Monocytes / drug effects
  • Monocytes / immunology
  • Receptors, Interleukin-2 / analysis*
  • Recombinant Proteins / pharmacology
  • Remission Induction

Substances

  • Antibodies, Monoclonal
  • Interleukin-2
  • Receptors, Interleukin-2
  • Recombinant Proteins